Examining the Real-World Effectiveness of the Movr App

April 26, 2021 updated by: Mary Jung, University of British Columbia

Examining the Real-World Effectiveness of the Movr mHealth Application: A Mixed-Methods Pilot Pragmatic Randomized Controlled Trial

The objective of this 8-week pilot pragmatic randomized controlled trial was to examine the real-world impact of movr on functional movement, flexibility, strength, and cardiovascular fitness.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Thousands of mobile apps available for download are geared towards health and fitness, yet limited research has evaluated the real-world effectiveness of such apps. The movr app is an mHealth app designed to enhance physical functioning by prescribing functional movement training based on individualized movement assessments. movr's influence on functional movement and physical fitness (flexibility, strength, and cardiovascular fitness) has not yet been established empirically. Thus, the objective of this 8-week pilot pragmatic randomized controlled trial was to examine the real-world impact of movr on functional movement, flexibility, strength, and cardiovascular fitness.

Study Type

Interventional

Enrollment (Actual)

48

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • British Columbia
      • Kelowna, British Columbia, Canada, V1V1V7
        • Diabetes Prevention Research Group Laboratory

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Ages 18 to 50 years
  • Ability to read and write English
  • Owned a mobile device that could download applications from the App Store or Google Play

Exclusion Criteria:

  • Previously used the movr app
  • Had any contraindications to exercise based on the Get Active Questionnaire

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: movr App Group
Participants were instructed to maintain their usual physical activity, diet, and sleep behavior for the 8-week intervention period and to avoid any specialized exercise training for that time period, but they were also asked to use the movr app to supplement their current activity.
The exercises prescribed through the movr app were accompanied with videos, images, and detailed instructions on how to complete them. These exercises consisted of basic movement and mobility patterns and are designed to promote functional movement. Participants were instructed to complete a total of four 'Minis' and two workout 'Builder' sessions per week. Workout Builders are designed to be longer exercise sessions tailored to the user's desired exercise time (15, 30, 45 or 60 min), equipment available (TRX Band, kettlebell, chin-up bar, dumbbells, foam roller, or none), target body region (lower, upper, or whole body), and specific exercise goal ('get sweaty,' 'build strength,' or 'develop mobility'). Version 3.6 of the movr app was used at the start of data collection and was updated to Version 4.1 over the course of the trial. No significant changes were made to the app or to the exercise prescription functionality throughout those updates.
No Intervention: Waitlist Control Group
Participants were instructed to maintain their usual physical activity, diet, and sleep behavior over the 8-week study period and to avoid any specialized exercise training for that time period. Following the 8-week study period, individuals in the control group were permitted to download and use the movr app if they chose to.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline in functional movement screen (FMS) at 8-week follow-up
Time Frame: Baseline and 8-week follow-up
The 100-point version of the functional movement screen (FMS) was used to identify individual movement patterns. The FMS is a screening tool to assess full body movement patterns and consists of seven core movement tests (deep squat, hurdle step, in-line lunge, active straight-leg raise, shoulder flexibility, trunk stability push-up, and quadruped rotary stability). The seven FMS movement screens were performed by each participant and recorded using a portable observation lab (Noldus) with two video cameras (one shot on a sagittal plane [side] view and the other from a frontal plane [front/back] view). The standardized FMS verbal instructions were provided by the researcher. The video-based testing was completed to minimize participant burden during lab visits and to blind participants to their FMS scores for each of the movements. Scoring of the FMS was completed at a later time using the video recordings.
Baseline and 8-week follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline in flexibility at 8-week follow-up
Time Frame: Baseline and 8-week follow-up
The shoulder reach flexibility test was used to assess upper body flexibility and the sit and reach, active straight-leg raise (ASLR), and the half-kneeling dorsiflexion tests were used to assess lower body flexibility. For the shoulder reach test, a soft tape measure was used to measure the distance between participants' closed fists, and for the ASLR, range of motion in degrees were measured on each leg using a digital inclinometer (Metriks, Canada). For each of the flexibility tests (excluding sit and reach), scores from the left and right side (arm or leg) were summed and total scores are reported. A lower measurement score on the shoulder flexibility test indicates greater flexibility, while higher scores on the sit and reach, ASLR, and half-kneeling dorsiflexion tests indicate greater flexibility.
Baseline and 8-week follow-up
Change from baseline in muscular endurance at 8-week follow-up
Time Frame: Baseline and 8-week follow-up
A push-up test was used to determine the maximal number of successive push-up repetitions that participants could complete until failure. The test protocols followed the Canadian Society for Exercise Physiology (CSEP) recommendations, including use of a modified push-up protocol for all women in the study.
Baseline and 8-week follow-up
Change from baseline in handgrip strength at 8-week follow-up
Time Frame: Baseline and 8-week follow-up
Handgrip strength was assessed using a maximal voluntary contraction of an isometric handgrip squeeze using a Smedley spring handgrip dynamometer (BASELINE®). Scores from the left and right hand were summed and total scores are reported.
Baseline and 8-week follow-up
Change from baseline in lower body power at 8-week follow-up
Time Frame: Baseline and 8-week follow-up
A countermovement jump (CMJ) was conducted using the My Jump 2 mobile app on an iPhone 8 to assess lower body power. The validity and reliability of the My Jump 2 has been established previously.
Baseline and 8-week follow-up
Change from baseline in cardiovascular fitness at 8-week follow-up
Time Frame: Baseline and 8-week follow-up
Participants performed an incremental maximal oxygen uptake (V̇O2max) test on a cycle ergometer (Lode Excalibur Sport). The resistance on the cycle ergometer was automatically increased (1W every 3 s for women, 1W every 2 s for men) until participants reached volitional exhaustion or could no longer maintain a pedal cadence of at least 50 rpm. A metabolic cart with an online gas collection system (Parvo Medics, TrueOne 2400) was used to collect expired gas samples continuously and V̇O2max was calculated using the mean of the highest average oxygen consumption over a 30-s period (in mL·kg-1·min-1).
Baseline and 8-week follow-up
Changes from baseline in health locus of control at 8-week follow-up
Time Frame: Baseline and 8-week follow-up
Form B of the Multidimensional Health Locus of Control Scale was used to measure health locus of control
Baseline and 8-week follow-up
Changes from baseline in perceptions of health at 8-week follow-up
Time Frame: Baseline and 8-week follow-up
The Short Form (36) Health Survey was used to assess perceptions of health status
Baseline and 8-week follow-up
Changes from baseline in physical activity enjoyment at 8-week follow-up
Time Frame: Baseline and 8-week follow-up
Enjoyment of physical activity completed over the past week was measured pre- and post-intervention using the Physical Activity Enjoyment Scale (PACES). This scale has 18 items that participants rated on a 7-point bipolar scale (from 1 to 7).
Baseline and 8-week follow-up
Changes from baseline in well-being, enjoyment, satisfaction with physical functioning at 1, 2, 3, 4, 5, 6, 7, and 8-week follow-up
Time Frame: Baseline and 1, 2, 3, 4, 5, 6, 7, and 8-week follow-up
The Subjective Exercise Experiences Scale (SEES) was used to measure participants' positive well-being, psychological distress and fatigue. The single-item Exercise Enjoyment Scale (EES) was used to measure exercise enjoyment. A 5-item measure of satisfaction with physical functioning was used assess participants' satisfaction with their (1) overall physical functioning, (2) cardiovascular fitness, (3) muscle strength, (4) flexibility, and (5) balance. This set of questions was administered at the end of each week throughout the 8-week intervention period as well as pre- and post-intervention in the form of an email that included a Qualtrics link to the survey
Baseline and 1, 2, 3, 4, 5, 6, 7, and 8-week follow-up
Semi-structured interviews completed at baseline and 8-week follow-up
Time Frame: Baseline and 8-week follow-up
At the very beginning of Visit 1 and at the end of Visit 2, a random sub-sample of 15 participants from the movr group participated in semi-structured interviews that were recorded using an audio recording device (Sony ICD PX333 Digital Voice Recorder). Interview questions addressed general beliefs about fitness mobile apps and perceptions of fitness and physical functioning, individual experiences with using the movr app, how exercise perceptions may change from before to after using the movr app, and how to optimize future design and delivery of the movr app
Baseline and 8-week follow-up

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes from baseline in moderate-to-vigorous physical activity at 8-week follow-up
Time Frame: Baseline and 8-week follow-up
Participants' physical activity levels were measured using the International Physical Activity Questionnaire - Short Form (IPAQ-SF)
Baseline and 8-week follow-up
Anthropometric measures completed at baseline and 8-week follow-up
Time Frame: Baseline and 8-week follow-up
Participants' height and body mass was assessed using a stadiometer
Baseline and 8-week follow-up
Changes from baseline in movr Movement Assessment scores at 4- and 8-week follow-up
Time Frame: Baseline, and 4- and 8-week follow-up
Participants were instructed to complete the 10 self-reported Movement Assessment tests through their individual movr app account. These movement tests are performed to assess mobility, motor control, and strength, and are used to determine deficiencies in movement patterns and to provide prescriptive information for exercise selection within the app. Participants were prompted (via email) to complete their Movement Assessments again at 4 and 8 weeks
Baseline, and 4- and 8-week follow-up
movr app usage data measured across 8-week study period and over 8-12-week voluntary follow-up
Time Frame: Across 8 week study period and over 8-12 week voluntary app usage period
The number of Minis and Builder sessions completed per week were recorded on the movr database server over the 8 week study period and additional voluntary use from 8-12 weeks
Across 8 week study period and over 8-12 week voluntary app usage period
movr app usability and acceptability measured at 8-week follow-up
Time Frame: 8-week follow-up
At the Visit 2 follow-up testing, participants were asked to respond to a series of Likert-type scale questions corresponding to the usability and acceptability of the movr app over the 8-week intervention period. In addition, questions included in the semi-structured interviews were also used to evaluate the usability and acceptability of the movr app
8-week follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Mary E Jung, PhD, University of British Columbia

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 25, 2019

Primary Completion (Actual)

February 14, 2020

Study Completion (Actual)

February 14, 2020

Study Registration Dates

First Submitted

April 26, 2021

First Submitted That Met QC Criteria

April 26, 2021

First Posted (Actual)

April 29, 2021

Study Record Updates

Last Update Posted (Actual)

April 29, 2021

Last Update Submitted That Met QC Criteria

April 26, 2021

Last Verified

April 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • H19-01915

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on movr mHealth App

Subscribe